초록 ▼

Disclosed are devices and methods for administration of charged drugs to tissues of the oral cavity and for intra-tissue administration. The disclosed drug applicator for intra-tissue use includes an introducer such as a needle or catheter that is adapted to penetrate into a living tissue. The intro

Disclosed are devices and methods for administration of charged drugs to tissues of the oral cavity and for intra-tissue administration. The disclosed drug applicator for intra-tissue use includes an introducer such as a needle or catheter that is adapted to penetrate into a living tissue. The introducer has a drug-providing portion, and the applicator has current-generating element to pass through it an electrical current. Passing an electrical current through the drug-providing portion causes the drug to eject into treated tissue. Also disclosed are charged drugs suitable for iontophoretic administration, which include a bioactive agent encapsulated in charged nano-particles.

대표청구항 ▼

1. A method for the administration of a bioactive to a tissue, comprising: contacting the tissue with a sponge configured to absorb and hold at least 30% w/w of an aqueous solution without dissolving or disintegrating, the sponge loaded with the bioactive encapsulated in charged nanoparticles; andpa

1. A method for the administration of a bioactive to a tissue, comprising: contacting the tissue with a sponge configured to absorb and hold at least 30% w/w of an aqueous solution without dissolving or disintegrating, the sponge loaded with the bioactive encapsulated in charged nanoparticles; andpassing a current through the sponge in a direction that moves the bioactive towards the tissue. 2. The method according to claim 1, wherein the sponge is a hydrogel. 3. The method according to claim 1, wherein the bioactive agent is non-charged. 4. The method according to claim 1, wherein the nanoparticles have a diameter of between 20 and 200 nm. 5. The method according to claim 1, wherein the tissue is selected from the group consisting of solid tumor, internal tissue, mucosal tissue, and tissue of the buccal cavity. 6. The method according to claim 1, wherein the nanoparticles are formed from complexes of ionic macromolecules with charged polymers. 7. The method according to claim 1, wherein the nanoparticles are nano-lipospheres. 8. The method according to claim 1, wherein contacting comprises inserting into the tissue the sponge loaded with the bioactive encapsulated charged nanoparticles, such that at least part of the charged nanoparticles eject into the tissue under the current. 9. The method according to claim 8, wherein the tissue is a solid tumor. 10. The method according to claim 1, wherein the tissue comprises tissue exposed during a chirurgic procedure, and contacting comprises administering the nanoparticles into the tissue. 11. A sponge for administration to a tissue of charged nanoparticles encapsulating a bioactive agent, comprising: a porous structure configured to absorb and hold at least 30% w/w of an aqueous solution without dissolving or disintegrating; andcharged nanoparticles encapsulating a bioactive agent and being loaded in the porous structure,wherein the sponge is configured to come into direct contact with the tissue and to release the charged nanoparticles under an electrical field. 12. The sponge according to claim 11, wherein the nanoparticles have a diameter of from 20 to 200 nm. 13. A method for the administration of a bioactive to a tissue, comprising: providing a dry sponge, configured to absorb and hold at least 30% w/w of an aqueous solution without dissolving or disintegrating, the dry sponge comprising a bioactive encapsulated in charged nanoparticles loaded in the dry sponge;contacting the tissue with the dry sponge loaded with the bioactive whereby the sponge swells; andpassing a current through the sponge in a direction that moves the bioactive towards the tissue. 14. A method for the administration of a bioactive to a tissue, comprising: providing a dry sponge, configured to absorb and hold at least 30% w/w of an aqueous solution without dissolving or disintegrating,swelling the dry sponge with an aqueous solution comprising a bioactive encapsulated in charged nanoparticles, to produce a swelled sponge loaded with the charged nanoparticles;contacting the tissue with the swelled sponge; andpassing a current through the swelled sponge in a direction that moves the bioactive towards the tissue. 15. A sponge for administration to a tissue of charged nanoparticles encapsulating a bioactive agent, consisting of: a porous structure configured to absorb and hold at least 30% w/w of an aqueous solution without dissolving or disintegrating; andcharged nanoparticles encapsulating a bioactive agent and being loaded in the porous structure,wherein the sponge is dry and is configured to come into direct contact with the tissue and to release the charged nanoparticles under an electrical field. 16. A sponge for administration to a tissue of charged nanoparticles encapsulating a bioactive agent, consisting of: a porous structure configured to absorb and hold at least 30% w/w of an aqueous solution without dissolving or disintegrating; andan aqueous solution comprising charged nanoparticles encapsulating a bioactive agent and being loaded in the porous structure,wherein the sponge is configured to come into direct contact with the tissue and to release the charged nanoparticles under an electrical field. 17. A drug applicator, comprising: an introducer comprising a sponge configured to absorb and hold at least 30% w/w of an aqueous solution without dissolving or disintegrating, the sponge comprising charged nanoparticles comprising a bioactive, the charged nanoparticles being loaded in the sponge, anda drug-providing portion that holds the sponge, the drug-providing portion being configured to contact a living tissue such that the sponge is in direct contact with the living tissue, and release the charged nanoparticles under electrical current, the introducer being configured to penetrate into the living tissue, such that passing an electrical current through the drug-providing portion when the introducer holding the sponge inside the tissue, causes the nanoparticles to eject; andmeans for passing the electrical current through the drug-providing portion. 18. The drug applicator of claim 17, wherein the sponge is a dry sponge.